| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.9 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.0022 | 0.9 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.0034 | 1 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |